Gou Qi Zi inhibits proliferation and induces apoptosis through the PI3K/AKT1 signaling pathway in non-small cell lung cancer

Background Gou Qi Zi (Lycium barbarum) is a traditional herbal medicine with antioxidative effects. Although Gou Qi Zi has been used to prevent premature aging and in the treatment of non-small cell lung cancer (NSCLC), its mechanism of action in NSCLC remains unclear. The present study utilized network pharmacology to assess the potential mechanism of action of Gou Qi Zi in the treatment of NSCLC. Methods The TCMSP, TCMID, SwissTargetPrediction, DrugBank, DisGeNET, GeneCards, OMIM and TTD databases were searched for the active components of Gou Qi Zi and their potential therapeutic targets in NSCLC. Protein-protein interaction networks were identified and the interactions of target proteins were analyzed. Involved pathways were determined by GO enrichment and KEGG pathway analyses using the Metascape database, and molecular docking technology was used to study the interactions between active compounds and potential targets. These results were verified by cell counting kit-8 assays, BrdU labeling, flow cytometry, immunohistochemistry, western blotting, and qRT-PCR. Results Database searches identified 33 active components in Gou Qi Zi, 199 predicted biological targets and 113 NSCLC-related targets. A network of targets of traditional Chinese medicine compounds and potential targets of Gou Qi Zi in NSCLC was constructed. GO enrichment analysis showed that Gou Qi Zi targeting of NSCLC was mainly due to the effect of its associated lipopolysaccharide. KEGG pathway analysis showed that Gou Qi Zi acted mainly through the PI3K/AKT1 signaling pathway in the treatment of NSCLC. Molecular docking experiments showed that the bioactive compounds of Gou Qi Zi could bind to AKT1, C-MYC and TP53. These results were verified by experimental assays. Conclusion Gou Qi Zi induces apoptosis and inhibits proliferation of NSCLC in vitro and in vivo by inhibiting the PI3K/AKT1 signaling pathway.

[1]  R. Roesler,et al.  Targeting Akt/PKB in Pediatric Tumors: A Review From Preclinical to Clinical Trials. , 2022, Pharmacological research.

[2]  Meng Li,et al.  The anti-aging activity of Lycium barbarum polysaccharide extracted by yeast fermentation: In vivo and in vitro studies. , 2022, International journal of biological macromolecules.

[3]  Yuzong Chen,et al.  Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents , 2021, Nucleic Acids Res..

[4]  Junzhi Sun,et al.  Cox-2 Antagonizes the Protective Effect of Sevoflurane on Hypoxia/Reoxygenation-Induced Cardiomyocyte Apoptosis through Inhibiting the Akt Pathway , 2021, Disease Markers.

[5]  Yue Zhang,et al.  Nickel nanoparticle-induced cell transformation: involvement of DNA damage and DNA repair defect through HIF-1α/miR-210/Rad52 pathway , 2021, Journal of Nanobiotechnology.

[6]  Shaoping Wang,et al.  A network pharmacology approach to investigate the anticancer mechanism of cinobufagin against hepatocellular carcinoma via downregulation of EGFR-CDK2 signaling. , 2021, Toxicology and applied pharmacology.

[7]  R. Rad,et al.  Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia , 2021, Nature Communications.

[8]  Xu Zhou,et al.  Network Pharmacology-Based Analysis of the Underlying Mechanism of Huajiao for Pain Relief , 2021, Evidence-based complementary and alternative medicine : eCAM.

[9]  Lianghui Zhan,et al.  Uncovering the Pharmacology of Xiaochaihu Decoction in the Treatment of Acute Pancreatitis Based on the Network Pharmacology , 2021, BioMed research international.

[10]  Joe Y. Chang,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  Guo-Dong Lu,et al.  Quercetin induces p53‐independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species‐dependent ferroptosis , 2021 .

[12]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[13]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[14]  Zheng Li,et al.  Advances in Pharmacological Actions and Mechanisms of Flavonoids from Traditional Chinese Medicine in Treating Chronic Obstructive Pulmonary Disease , 2020, Evidence-based complementary and alternative medicine : eCAM.

[15]  Guo-Dong Lu,et al.  Quercetin induces p53‐independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species‐dependent ferroptosis , 2020, British journal of pharmacology.

[16]  J. Sharifi‐Rad,et al.  Quercetin and MicroRNA Interplay in Apoptosis Regulation in Ovarian Cancer. , 2020, Current pharmaceutical design.

[17]  H. Kuang,et al.  Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer , 2020, Chinese medical journal.

[18]  Zhenzhong Wang,et al.  Systems pharmacology reveals the multi-level synergetic mechanism of action of Ginkgo biloba L. leaves for cardiomyopathy treatment. , 2020, Journal of ethnopharmacology.

[19]  Xiao B. Huang,et al.  Lycium barbarum Polysaccharide Inhibited Hypoxia-Inducible Factor 1 in COPD Patients , 2020, International journal of chronic obstructive pulmonary disease.

[20]  F. Fujita,et al.  Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In Vitro , 2020, AntiCancer Research.

[21]  Xiaoping Gao,et al.  Lycium barbarum Polysaccharide Extracted from Lycium barbarum Leaves Ameliorates Asthma in Mice by Reducing Inflammation and Modulating Gut Microbiota. , 2020, Journal of medicinal food.

[22]  N. Xing,et al.  Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways , 2020, International journal of biological sciences.

[23]  H. Ljunggren,et al.  Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2 , 2020, PLoS pathogens.

[24]  Liangfang Shen,et al.  VCAM-1 Secreted from Cancer-Associated Fibroblasts Enhances the Growth and Invasion of Lung Cancer Cells through AKT and MAPK Signaling. , 2020, Cancer letters.

[25]  Hong-wei Wang,et al.  Lycium barbarum polysaccharides attenuate kidney injury in septic rats by regulating Keap1-Nrf2/ARE pathway. , 2019, Life sciences.

[26]  A. Bishayee,et al.  Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy. , 2019, Seminars in cancer biology.

[27]  V. Rotter,et al.  Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis , 2019, International journal of molecular sciences.

[28]  A. Alzahrani.  PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. , 2019, Seminars in cancer biology.

[29]  G. Goss,et al.  Third-generation epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer. , 2019, Translational lung cancer research.

[30]  Chiun-Sheng Huang,et al.  Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer , 2019, Clinical Cancer Research.

[31]  Xuan Zhan,et al.  Effects of Lycium barbarum Polysaccharides on Health and Aging of C. elegans Depend on daf-12/daf-16 , 2019, Oxidative medicine and cellular longevity.

[32]  Chengying Hong,et al.  Attenuation of hyperoxic acute lung injury by Lycium barbarum polysaccharide via inhibiting NLRP3 inflammasome , 2019, Archives of Pharmacal Research.

[33]  F. Liu,et al.  Lycium barbarum polysaccharide induced apoptosis and inhibited proliferation in infantile hemangioma endothelial cells via down-regulation of PI3K/AKT signaling pathway , 2019, Bioscience reports.

[34]  R. Veitia,et al.  High-throughput Exploration of the Network Dependent on AKT1 in Mouse Ovarian Granulosa Cells. , 2019, Molecular & cellular proteomics : MCP.

[35]  J. Das,et al.  Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy. , 2019, Materials science & engineering. C, Materials for biological applications.

[36]  Qihui Zhang,et al.  Quercetin is the Active Component of Yang-Yin-Qing-Fei-Tang to Induce Apoptosis in Non-Small Cell Lung Cancer. , 2019, The American journal of Chinese medicine.

[37]  Shenglong Li,et al.  Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Y. Hseu,et al.  Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis , 2019, Journal of Experimental & Clinical Cancer Research.

[39]  G. Fairn,et al.  Akt-ing Up Just About Everywhere: Compartment-Specific Akt Activation and Function in Receptor Tyrosine Kinase Signaling , 2019, Front. Cell Dev. Biol..

[40]  Yang Liu,et al.  Anemoside B4 exerts anti-cancer effect by inducing apoptosis and autophagy through inhibiton of PI3K/Akt/mTOR pathway in hepatocellular carcinoma. , 2019, American journal of translational research.

[41]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[42]  Shumin Xu,et al.  Lycium barbarum polysaccharide reduces hyperoxic acute lung injury in mice through Nrf2 pathway. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  Zhidong Lv,et al.  p53-independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells , 2018, Oncology letters.

[44]  Jing Zhao,et al.  Hypoxia-Inducible Factor 1-α (HIF-1α) Induces Apoptosis of Human Uterosacral Ligament Fibroblasts Through the Death Receptor and Mitochondrial Pathways , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[45]  Jian-min Li,et al.  Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway , 2018, Bioscience reports.

[46]  Eric C. Polley,et al.  Interaction between the microbiome and TP53 in human lung cancer , 2018, Genome Biology.

[47]  Xueqing Zhang,et al.  Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[48]  Gang Wang,et al.  Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial. , 2018, Respiratory medicine.

[49]  XY Zhang,et al.  Stimulatory effects of curcumin and quercetin on posttranslational modifications of p53 during lung carcinogenesis , 2018, Human & experimental toxicology.

[50]  Rong Wang,et al.  Quercetin suppresses breast cancer stem cells (CD44+/CD24−) by inhibiting the PI3K/Akt/mTOR‐signaling pathway , 2018, Life sciences.

[51]  S. Gadgeel,et al.  Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer , 2018, Expert review of anticancer therapy.

[52]  Evan Bolton,et al.  Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..

[53]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[54]  Zhenghua Fei,et al.  Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[55]  H. Guan,et al.  System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus , 2017, Front. Pharmacol..

[56]  M. Duffy,et al.  Mutant p53 as a target for cancer treatment. , 2017, European journal of cancer.

[57]  J. Colinge,et al.  Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels. , 2017, Cancer research.

[58]  Olivier Michielin,et al.  SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.

[59]  Kristofer C. Berrett,et al.  MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition. , 2017, Cancer cell.

[60]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[61]  M. Aoki,et al.  Oncogenic Roles of the PI3K/AKT/mTOR Axis. , 2017, Current topics in microbiology and immunology.

[62]  Yayun Qian,et al.  Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis , 2016, Molecular medicine reports.

[63]  R. Franco,et al.  Analysis of NSCLC tumour heterogeneity, proliferative and 18F‐FDG PET indices reveals Ki67 prognostic role in adenocarcinomas , 2016, Histopathology.

[64]  N. Tosic,et al.  Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia , 2016, Journal of medical biochemistry.

[65]  A. Nicholson,et al.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[66]  C. Dang,et al.  MYC and metabolism on the path to cancer. , 2015, Seminars in cell & developmental biology.

[67]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[68]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[69]  Aurélien Grosdidier,et al.  SwissTargetPrediction: a web server for target prediction of bioactive small molecules , 2014, Nucleic Acids Res..

[70]  Jinzhong Chen,et al.  Lycium barbarum Polysaccharides Prevent Memory and Neurogenesis Impairments in Scopolamine-Treated Rats , 2014, PloS one.

[71]  O. Sagol,et al.  Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma , 2013, Oncology reports.

[72]  P. Surowiak,et al.  Quercetin inhibits proliferation and increases sensitivity of ovarian cancer cells to cisplatin and paclitaxel. , 2013, Ginekologia polska.

[73]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[74]  Yuling Chen,et al.  Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax. , 2013, Life sciences.

[75]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[76]  Damian Szklarczyk,et al.  STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..

[77]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[78]  A. Ziemienowicz,et al.  Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. , 2011, Annals of botany.

[79]  Katharina D'Herde,et al.  Apoptosis and necrosis: detection, discrimination and phagocytosis. , 2008, Methods.

[80]  R. Chang,et al.  Use of Anti-aging Herbal Medicine, Lycium barbarum, Against Aging-associated Diseases. What Do We Know So Far? , 2008, Cellular and Molecular Neurobiology.

[81]  P. Piccaluga,et al.  Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients , 2006, Leukemia.

[82]  T. Fan,et al.  Caspase family proteases and apoptosis. , 2005, Acta biochimica et biophysica Sinica.

[83]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[84]  J. Gera,et al.  Downstream effectors of oncogenic ras in multiple myeloma cells. , 2003, Blood.

[85]  Tsviya Olender,et al.  Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE , 2003, Nucleic Acids Res..

[86]  J. Gutkind,et al.  Loss of PTEN expression leading to high Akt activation in human multiple myelomas. , 2000, Blood.

[87]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[88]  G. Cao,et al.  [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients]. , 1994, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[89]  C. X. Lu,et al.  [Radiosensitizing effects of Lycium barbarum polysaccharide for Lewis lung cancer]. , 1991, Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine.

[90]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.